Patent · US Active

Use of a GABAA receptor allosteric enhancer in medicine

US11684591B2 · kind B2 · utility

0Cited by

1References

3Claims

0Family size

Assignee

XI'AN LIBANG ZHAOXIN BIOTECHNOLOGY CO., LTD · CN

Inventors

Rutao Wang · Tuji, CN
Long An · Xi'an, CN
Yi Zhao · South Pasadena, US
Jinghua Pang · Xi'an, CN
Tao Chen · 安丰镇, CN
Weijiao Wang · Tuji, CN

Key dates

Filing date	Jul 10, 2019
Grant date	Jun 27, 2023
Priority date	—
Expiry date	Jul 10, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/24
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

An application of a GABAA receptor allosteric enhancer in medicine. Specifically provided is use of the GABAA receptor allosteric enhancer shown in formula (I) in preparation of drugs for sedatives, hypnosis, treatment or prevention of anxiety, depression, insomnia, nausea, vomiting, migraine, schizophrenia, convulsions, and

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.